<table class="table table-striped table-hover" style="width: auto !important; margin-left: auto; margin-right: auto;">
 <thead>
  <tr>
   <th style="text-align:left;"> Steps in ablation analysis </th>
   <th style="text-align:left;"> Datasource TEST </th>
   <th style="text-align:left;"> Datasource TEST2 </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> Subjects with at least one disease diagnosis during study period, Main, n </td>
   <td style="text-align:left;"> 9 </td>
   <td style="text-align:left;"> 10 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects with at least one disease diagnosis during study period, Ablation analysis keeping PC, n (%) </td>
   <td style="text-align:left;"> 9 (100%) </td>
   <td style="text-align:left;"> 9 (100%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects with at least one disease diagnosis during study period, Ablation analysis keeping Inpatient and medicines, n (%) </td>
   <td style="text-align:left;"> 9 (100%) </td>
   <td style="text-align:left;"> 9 (100%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects with at least one disease diagnosis during study period, Ablation analysis keeping Inpatient, specialist and medicines, n (%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> At least one disease diagnosis during look-back, Main, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> At least one disease diagnosis during look-back, Ablation analysis keeping PC, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> At least one disease diagnosis during look-back, Ablation analysis keeping Inpatient and medicines, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> At least one disease diagnosis during look-back, Ablation analysis keeping Inpatient, specialist and medicines, n </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Additional exclusion criterion, Main, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Additional exclusion criterion, Ablation analysis keeping PC, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Additional exclusion criterion, Ablation analysis keeping Inpatient and medicines, n </td>
   <td style="text-align:left;"> 0 </td>
   <td style="text-align:left;"> 0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Additional exclusion criterion, Ablation analysis keeping Inpatient, specialist and medicines, n </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, Main, n </td>
   <td style="text-align:left;"> 9 </td>
   <td style="text-align:left;"> 9 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, Ablation analysis keeping PC, n </td>
   <td style="text-align:left;"> 9 </td>
   <td style="text-align:left;"> 9 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, only in main and not in PC, n (%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects in both main and PC, n (%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, Ablation analysis keeping Inpatient and medicines, n </td>
   <td style="text-align:left;"> 9 </td>
   <td style="text-align:left;"> 9 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, only in main and not in Inpatient and medicines, n (%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects in both main and Inpatient and medicines, n (%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
   <td style="text-align:left;"> 0 (0%) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, Ablation analysis keeping Inpatient, specialist and medicines, n </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects included in the study cohort, only in main and not in Inpatient, specialist and medicines, n (%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Subjects in both main and Inpatient, specialist and medicines, n (%) </td>
   <td style="text-align:left;"> NA </td>
   <td style="text-align:left;"> NA </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Days from start of study period (1/1/2017) and first disease diagnosis (cohort entry) in the main analysis, median (IQ range) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Days from start of study period (1/1/2017) and first disease diagnosis (cohort entry), in the ablation analysis keeping PC median (IQ range) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Days from start of study period (1/1/2017) and first disease diagnosis (cohort entry), in the ablation analysis keeping Inpatient and medicines median (IQ range) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
   <td style="text-align:left;"> 827 (153-1382) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Days from start of study period (1/1/2017) and first disease diagnosis (cohort entry), in the ablation analysis keeping Inpatient, specialist and medicines median (IQ range) </td>
   <td style="text-align:left;"> NA (NA-NA) </td>
   <td style="text-align:left;"> NA (NA-NA) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Difference between cohort entry date in the main cohort and in the ablation analysis keeping PC, median (IQ range) </td>
   <td style="text-align:left;"> 0 (0-0) </td>
   <td style="text-align:left;"> 0 (0-0) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Difference between cohort entry date in the main cohort and in the ablation analysis keeping Inpatient and medicines, median (IQ range) </td>
   <td style="text-align:left;"> 0 (0-0) </td>
   <td style="text-align:left;"> 0 (0-0) </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Difference between cohort entry date in the main cohort and in the ablation analysis keeping Inpatient, specialist and medicines, median (IQ range) </td>
   <td style="text-align:left;"> NA (NA-NA) </td>
   <td style="text-align:left;"> NA (NA-NA) </td>
  </tr>
</tbody>
</table>
